[DISCLOSURE] KDPharm (011040) announced on July 28 that it will repurchase 150,000 common stocks worth 2.88 billion won (US$2.55 million).
The stocks will be traded on Kosdaq by Oct. 27. The repurchased stocks will contribute to stabilization of its stock price and increasing value for stockholders.
The stocks will be traded on Kosdaq by Oct. 27. The repurchased stocks will contribute to stabilization of its stock price and increasing value for stockholders.